High-throughput liquid-chromatography method with fluorescence detection for reciprocal determination of furosemide or norfloxacin in human plasma

Biomedical Chromatography

Volumn 21, Issue 1, 2007, Pages 40-47

  Galaon, Toma ^a   Udrescu, Stefan ^a   Sora, Iulia ^a   David, Victor ^a,b   Medvedovici, Andrei ^a,b  

^a LaborMed Pharma SA   (Romania)

^b UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

Fluorescence detection; Furosemide; Human plasma; Liquid chromatography; Norfloxacin

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; FLUORESCENCE; LIQUID CHROMATOGRAPHY; ORGANIC SOLVENTS; PLASMA (HUMAN); THROUGHPUT;

EMISSION WAVELENGTH; EXCITATION WAVELENGTH; FLUORESCENCE DETECTION; FUROSEMIDES; HIGH-THROUGHPUT; HPLC-FLD; HUMAN PLASMAS; INTERNAL STANDARDS; NORFLOXACIN; SIMPLE++;

ACETONITRILE;

ACETONITRILE; FUROSEMIDE; HEPTANE; METHANOL; NORFLOXACIN; ORGANIC SOLVENT; SULFONIC ACID DERIVATIVE; TRIETHYLAMINE;

ACCURACY; ANALYTICAL PARAMETERS; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG ISOLATION; DRUG STABILITY; DRUG STRUCTURE; FEMALE; FLOW RATE; FLUORESCENCE ANALYSIS; FREEZE THAWING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN EXPERIMENT; HYDROPHOBICITY; LINEAR SYSTEM; MALE; NORMAL HUMAN; PH MEASUREMENT; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SPECTRAL SENSITIVITY;

EID: 33846545587     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.715     Document Type: Article

References (21)

1. Abdel-Hamid ME. High-performance liquid chromatography-mass spectrometric analysis of furosemide in plasma and its use in pharmacokinetic studies. II Farmaco 2000; 55: 448-454.
2. Abou-Auda HS, Al-Yamani MJ, Morad AM, Bawazir SA, Khan SZ and al-Khamis KI. High-performance liquid chromatographic determination of furosemide in plasma and urine and its use in bioavallability studies. Journal of Chromatography B: Biomedical Sciences and Applications 1998; 710: 121-128.
3. Anadon A, Martinez-Larranaga MR, Velez C, Diaz MJ and Bringas P. Pharmacokinetics of norfloxacin and its N-desethyl- and oxo-metabolites in broiler chickens. American Journal of Veterinary Research 1992; 53: 2084-2089.
4. + excretion by furosemide and piretanide: role of bradykinin. Journal of American Society of Nephrology 2004; 15: 876-884.
5. Campins-Falco P, Herraez-Hernandez R and Pastor-Navarro MD. Analysis of diuretics in urine by column-switching chromatography and fluorescence detection. Journal of Liquid Chromatography and Related Technology 1997; 20: 1867-1885.
6. Farthing D, Kames T, Gehr TW, Match C, Fakhry I and Sica DA. External-standard high-performance liquid chromatographic method for quantitative determination of furosemide in plasma by using solid-phase extraction and on-line elution. Journal of Pharmaceutical Science 1992; 81: 569-571.
7. Gaillard Y and Pepin G. Use of high-performance liquid chromatography with photodiode-array UV detection for the creation of a 600-compound library application to forensic toxicology. Journal of Chromatography A 1997; 763: 149-163.
8. Gomez C, von Plessin C, Godoy CG, Reinbach R and Godoy R. Method validation for the determination of furosemide in human plasma by liquid-tiquid extraction and high-performance liquid chromatography with fluorescence detection. Journal of Chilean Chemistry Society 2005; 50: 479-481.
9. Jankowski A, Skorek-Jankowska A and Lamparczyk H. Determination and pharmacokinetics of a furosemide-amiloride drug combination. Journal of Chromatography B: Biomedical Sciences and Applications 1997; 693: 383-391.
10. Lim L, Park Band Yun H. Sensitive liquid chromatographic-mass spectrometric assay for norfloxacin in poultry tissue. Journal of Chrornatography B: Biomedical Sciences and Applications 2002; 772: 185-189.
11. McCurley JM, Hanlon SU, Wei SK, Wedam EF, Michalski M and Haigney MC. Furosemide and the progression of left ventricular dysfunction in experimental heart failure. Journal of the American College of Cardiology 2004; 15: 1301-1307.
12. Meylan WM and Howard PH. Atom/fragment contribution method for estimating octanol-water partition coefficients. Journal of Pharmaceutical Science 1995; 84: 83-92.
13. Nava-Ocampo AA, Velazquez-Armenta EY, Reyes-Perez H, Ramirez-Lopez E and Ponce-Monter H. Simplified method to quantify furosemide in urine by high-performance liquid chromatography and ultraviolet detection. Journal of Chromatography B: Biomedical Sciences and Application 1996: 682: 343-348.
14. Okuda T, Yamashita K and Motohashi M. High-performance liquid chromatography using on-line solid-phase extraction: determination of furosemide in human serum. Journal of Chromatography B: Biomedical Sciences and Applications 1996; 682: 343-348.
15. Reeuwijk HJ, Tjaden UR and van der Greef J. Simultaneous determination of furosemide and amiloride in plasma using high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B: Biomedical Sciences and Applications 1992; 575: 269-274.
16. Sidhu JS and Charles BG. Simple microscale high-performance liquid chromatographic method for determination of furosemide in neonatal plasma. Journal of Chromatography B: Biomedical Sciences and Applications 1993; 612: 161-165.
17. Singh AK, McArdle C, Gordon B, Ashraf M and Granley K. Simultaneous analysis of furosemide and bumetanide in horse plasma using high performance liquid chromatography. Biomedical Chromatography 1989; 3: 262-265.
18. Takamura N, Maruyama T and Otagiri M. Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia. Clinical Chemistry 1997; 43: 2274-2280.
19. Uchida T, Yamanaga K, Nishikawa M, Ohtaki Y, Kido H and Watanabe M. Anti-aldosteronergic effect of torasemide. European Journal of Pharmacology 1991; 205: 145-150.
20. Vybiralova Z, Nobilis M, Zoulova J, Kvetina J and Petr P. High-performance liquid chromatographic determination of ciprofloxacin in plasma samples. Journal of Pharmaceutical and Biomedical Analysis 2005; 37: 851-858.
21. Zendelovska D and Stafilov T. Sample preparation and RPHPLC determination of diuretics in human body fluids. Acta Pharmaceutica 2006; 56: 115-142.